透明质酸生产菌的诱变选育

以马链球菌为出发菌株, 通过紫外线和60Co-γ射线辐照诱变, 得到一株无溶血性菌株NC1150, 并在此基础上继续用60Co-γ射线辐照诱变得到产量较高的菌株NC168, 使透明质酸产量与出发菌株NC1150相比提高了101%, 相对分子量为0.55×106 D, 突变株经过多次传代, 透明质酸产量和相对分子量保持稳定, 溶血性无回复突变现象。     

原生质体诱变选育高产异抗坏血酸菌株

以灰黄青霉菌(Penicillium griseofulvum HL)为出发菌株,试验得到灰黄青霉原生质体制备的优化条件为:菌体培养48h,用0.7mol/L的NaC1溶液作为渗透压稳定剂,用0.5％的蜗牛酶+0.5％的纤维素酶,在pH为6,30℃条件下酶解3h,所得原生质体数最多,达到3.14×107/ml.原生质体再生的最佳条件为采用双层平板培养法,在用0.7mol/L的蔗糖溶液配制的改进察氏培养基上其再生率最高,达到24.93％.灰黄青霉原生质体经过紫外线诱变,DES诱变,紫外线-DES诱变复合诱变,紫外线-氯化锂复合诱变选育异抗坏血酸高产菌株,通过对再生平板上长出的诱变菌株进行初筛和摇瓶复筛,最终获得一株异抗坏血酸产量较高的菌株ZD4,其产量为5.28mg/ml,提高到出发菌株产量(1.08 mg/ml)的488.9％,且连续传代6代遗传稳定.     

微波诱变选育井冈霉素高产菌

采用微波诱变方法对井冈毒素生产菌株（Streptomyces hygroscopicus var.Jinggangensis Yen)进行诱变处理,挑取单个菌落摇瓶初筛,复筛,测定化学效价,获得4株平均效价比出发菌株分别高出17．5％、15％、20％、21．7％的突变株。沙土管保存10个月后,取沙土管孢子接种斜面连续传代4次,测定化学效价,代间效价差异不明显,遗传性能稳定。     

高产马杜霉素产生菌的诱变选育

研究马杜拉放线菌的筛选,比较代表5类不同诱变剂UV,EMS,LiCl+UV和NTG的处理效果,经摇瓶验证,用NTG处理后经过初筛、复筛得到摇瓶效价比对照菌株高91.5％的诱变菌株348＃,稳定性考查后,在2.5m~3和50m~3发酵罐上进行试生产,效果显著,菌种代谢速度加快,效价比对照罐高60％,主要组分A组分的含量由91％增长到96.5％,提高了经济效益。     

透明质酸产生菌SH-2发酵条件的优化

对经紫外诱变,筛选出的突变菌株马疫链球菌SH-2,进行发酵条件的优化实验,通过单因素实验确定最佳摇瓶条件是种龄14-16h,初始pH7.6,发酵温度37℃,发酵时间44h;通过多因素正交实验摸索出营养培养基的最佳配比为:葡萄糖5%,酵母粉6.67%,牛肉膏3.33%,MgSO4·7H2O0.1%,MnSO4·4H2O0.02%,NaHCO30.3%,Na2HPO40.15%,NaCl0.3%,UTP0.05%,异甘草素0.08‰。     

高产磷酯酶C菌株的诱变选育

在前面进行的高产磷酯酶C(PLC)菌株筛选、分类鉴定及其抗血小板功能研究的基础上,对选育出的高产PLC菌株BacilluscereusShenZhen7541进行了紫外线和Co60γ射线诱变处理,以期提高其产PLC的水平,从而有利于PLC的纯化制备。B.cereus7541经过三次紫外线照射及两次Co60γ射线辐射诱变处理,通过分离与卵黄琼脂杯碟法及NPPC法酶活检验筛选,最终获得了三株高产PLC突变菌株9287、9289和5612,其产PLC酶活水平分别达到14.878±1.428u/mL、16.450±0.793u/mL、16.400±0.967u/mL,较原始出发菌株B.cereus7541产酶水平(5.803±0.793u/mL)分别提高了2.879、3.236和3.226倍。经t值检验,三株菌产PLC水平与7541差异均达极显著(P<0.001)。     

酸奶生产菌株的诱变选育

通过诱变选育高产酸力菌株;首先采用紫外线和亚硝基胍对乳酸菌进行单因素诱变,确定紫外线照射剂量为150s,并得到一株产酸力为57.85°T的菌株,比原菌株产酸力提高了3.05%;NTG的诱变剂量是0.3mg/mL,处理时间为60min,得到产酸力为58.02°T的菌株,较出发菌株提高了6.52%。接着以紫外线和NTG对高产酸菌株进行了2轮复合诱变,最终得到产酸力达83.66°T的诱变株,较出发菌株产酸力提高了30.64%。     

复合诱变黑曲霉选育β—葡萄糖苷酶高产菌株

对黑曲霉原生质体进行紫外、ＬｉＣｌ复合诱变,观察诱变后原生质体再生菌落,发现了孢子色变异较大的菌株,且其变化与酶产量相关。经发酵筛选,获得β－葡萄糖苷酶活较高菌株,其酶活由出发菌株的１０ｕ／ｍｌ提高到１４．７ｕ／ｍｌ。再对高产突变株进行氮离子注入,酶活又提高２０％（达１７ｕ／ｍｌ）。     

马疫链球菌SH-5生产透明质酸营养条件的研究

对Streptococcus equiSH-5生产透明质酸的营养条件进行了研究,摇瓶发酵实验表明该菌株的适宜氮源为酵母膏和牛肉膏以2∶1组成的混合氮源,在碳氮比为2∶1时有利于透明质酸的合成和菌体的生长;通过正交实验摸索出营养培养基的最佳配比为葡萄糖5%,酵母粉6.67%,牛肉膏3.33%,MgSO4.7H2O 0.1%,MnSO4.4H2O 0.02%,NaHCO30.3%,Na2HPO40.5‰,尿嘧啶0.08‰;添加0.05‰异甘草素对产酸有利。     

空间诱变在微生物菌种选育上的研究进展

空间诱变是一种新型有效的微生物育种手段。本主要综述国内外微生物空间条件诱发微生物突变的特点、生物学、细胞学、当代生理损伤效应、突变的机理以及育种中已取得的进展,并提出了存在的问题和今后研究的发展方向。     

马链球菌马亚种IgG结合蛋白的原核表达和免疫原性

为研究马链球菌马亚种IgG结合蛋白(EAG)免疫原性和保护力,评价其作为马链球菌疫苗抗原的价值。采用PCR法扩增马链球菌马亚种EAG基因,将测序正确的EAG扩增产物与原核表达载体pET-28a(+)连接构建重组质粒,对转化后的大肠杆菌进行诱导表达,用诱导纯化后的重组蛋白作免疫原免疫小鼠,分析重组蛋白免疫小鼠后的抗体水平及对小鼠的免疫保护力。结果表明,诱导后可得到26 kDa的EAG重组蛋白,且该蛋白可与该菌阳性血清发生特异性反应。间接ELISA检测免疫小鼠的抗体效价可达1∶8 100,重组蛋白免疫后对小鼠保护力可达90%。该结果表明,表达的EAG蛋白具有良好的抗原性,可有效提高小鼠的体液免疫水平及免疫保护力。     

Neither the A- nor B-repeat regions of the fibrinogen-binding protein of Streptococcus equi subsp. equi are essential for fibrinogen binding

The major cell wall-associated protein (FgBP) of Streptococcus equi subsp. equi possesses two internal blocks of repeated sequence (A and B) and binds horse fibrinogen (Fg) avidly through residues located in the N-terminal half of the molecule. In the present study, we investigated the roles of the two repeats blocks in Fg binding through construction of recombinant FgBP proteins containing defined internal deletions of sequence. Ligand binding experiments clearly showed that neither repeat is essential for Fg binding. However, residues within the B repeats seem to play a major role in the aberrant mobility observed for FgBP following sodium dodecyl sulfate polyacrylamide gel electrophoresis.     

IdeE, an IgG-endopeptidase of Streptococcus equi ssp. equi

Streptococcus equi ssp. equi is the causative agent of strangles, a highly contagious and serious disease in the upper respiratory tract of horses. The present study describes the characterization of IdeE, a homolog of the secreted IgG-specific protease IdeS/Mac of Streptococcus pyogenes. The activity of IdeE is compared with the activity of IdeZ, the corresponding enzyme of the closely related S. equi ssp. zooepidemicus. A study of the proteolytic activity of recombinant IdeE and IdeZ on IgG from a selection of mammals shows that only antibodies containing the substrate site of IdeS/Mac are cleaved, indicating that the specificities of these enzymes are similar. Interestingly, IgG from horse is less effectively cleaved than IgG from e.g. dog or humans, as the dominating IgG isotype in horse sera (IgG4) lacks a distinct substrate site for IdeE/IdeZ. IgG-degradation is observed when S. equi ssp. equi is grown in the presence of horse serum, but not when grown with purified IgG. As the fraction of degraded IgG contains IgG4, the observed activity might be due to the expression of an unknown enzyme rather than IdeE. In a similar assay, no proteolysis of IgG was detected in the growth media of S. equi ssp. zooepidemicus.     

Effect of p-nitrophenol metabolites on microbial cell electro-optical characteristics

The major cell wall-associated protein of the equine pathogen Streptococcus equi subsp. equi is a fibrinogen-binding protein (FgBP) which binds horse fibrinogen and equine IgG-Fc avidly through residues located in the N-terminal half and central regions of the molecule, respectively. The molecule is a major virulence factor for the organism and displays protective potential. In the present study, we use circular dichroism spectroscopy to investigate the secondary structure of the protein and show through the analysis of a panel of recombinant FgBP truncates that the C-terminal portion of FgBP contains an extensive alpha-helical coiled-coil structure that contributes to the thermal stability of the molecule.     

Identification and characterization of a novel fibronectin-binding protein gene from Streptococcus equi subspecies zooepidemicus strain VTU211

This work describes the cloning and sequencing of genes encoding fibronectin-binding proteins from Streptococcus equi subspecies zooepidemicus strain VTU211. A gene encoding a cell-wall protein FNZ was amplified and sequenced. In the same bacterial strain, a second gene termed fnz2 was now discovered, encoding another fibronectin-binding protein (FNZ2). The complete amino acid sequence encoded by fnz2 was deduced and compared to that deduced from fnz. The sequence comparison of the fnz and fnz2 predicted that fibronectin-binding activity is localizing a domain in the C terminal part of FNZ2, since this domain is composed of three repeats, which contain a motif similar to what has earlier been found in other fibronectin-binding proteins in streptococci. Three parts of fnz2 [fnz2(1-8), fnz2(2-4), and fnz2(4-3)] were amplified using polymerase chain reaction and ligated into an expression vector, and recombinant FNZ2 proteins were produced in Escherichia coli. Fibronectin bound to the FNZ2(1-8) [amino acids 212-396] and FNZ2(2-4) (amino acids 36-448) but not to the FNZ2(4-3) (amino acids 36-191) in a Western ligand blot, showing that repeat domain of FNZ2 protein was sufficient for binding of fibronectin. Purified FNZ2(2-4) protein was also shown to display collagen-binding activity to collagen-coated microtiter wells. These results show that recombinant FNZ2 has fibronectin- and collagen-binding activities.